Abstract
The paper presents the study results of a drug designed to treat and prevent postpartum uterine inflammatory diseases in cows based on quinazoline - Hinasept-gel. The authors used the results of a toxicological study, the study of antimicrobial activity, its study of hematological parameters, natural resistance, and the identification of the prophylactic and therapeutic efficacy of Hinasept-gel. The authors also found that the drug has a complex therapeutic effect, showing a high preventive (85.2%) and therapeutic (96.4%) effect, accompanied by improved livestock reproduction. In addition, the drug does not have a toxic effect on animals in therapeutic doses, does not have an allergenic and sensitizing impact, and does not irritate the uterine mucosa. Also, the medicine normalizes the main hematological and immunological parameters within 15 days of its use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
